HouseOversight-UnsustainableDrugPrices-PartIII-2021 May 19, 2021 Rep. Carolyn B. Maloney Chairwoman of the Committee on Oversight and Reform U.S. House of Representatives Rep. James Comer Ranking Member of the Committee on Oversight and Reform U.S. House of Representatives Re: Request for statement… Continue Reading
Ahead of the 74th World Health Assembly, Health Action International, Knowledge Ecology International, and Medicines Law & Policy will be co-hosting a discussion with a high-level panel on what a pandemic response treaty should say about the sharing of rights… Continue Reading
On May 18th, the People’s Vaccine Alliance sent Justin Trudeau, Prime Minister of Canada, a letter urgently requesting that vaccines, therapeutics and diagnostics for COVID-19 be added to Schedule 1 of the Patent Act. Below is the text of the PVA… Continue Reading
On Monday, 17 May 2021, the 62 co-sponsors of a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19 (IP/C/W/669) published a joint statement (IP/C/W/677) on COVID-19. This joint statement foreshadows the revised… Continue Reading
Allele is accusing Pfizer and BioNTech of infringing one of their patents during the research that led to their COVID-19 vaccine, according to a complaint recently filed in a federal court in California, United States. The case relates to U.S.… Continue Reading
On April 27th, a letter signed by 41 Canadian experts was sent to the Prime Minister of Canada, the Minister of Innovation, Science & Industry, and the Minister of Health. The letter requests the amendment of Schedule 1 of the… Continue Reading
On 4 December 2020, Ethiopia submitted a Zero Draft resolution to the World Health Organization (WHO) on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access – WHO Resolution on Strengthening Local Production of Medicines and Other… Continue Reading
On March 31, 2020, KEI received a copy of the contract between Johnson & Johnson (“J&J”) and the Department of Health and Human Services (HHS) for the development of J&J’s COVID-19 vaccine.The contract, which is now valued at $1.3 billion,… Continue Reading
A March 21, 2021 New York Times article on vaccine access discusses how a technology invented and owned by the National Institutes of Health (NIH) is necessary to make several COVID-19 vaccines. The invention mentioned by the Times, titled Prefusion… Continue Reading